Positions

Selected Publications

Academic Article

Year Title Altmetric
2022 Hyperintensity of integrin-targeted fluorescence agent IntegriSense750 accurately predicts flap necrosis compared to Indocyanine green 2022
2021 Author Correction: Positron emission tomography imaging with 89Zr-labeled anti-CD8 cys-diabody reveals CD8+ cell infiltration during oncolytic virus therapy in a glioma murine model (Scientific Reports, (2021), 11, 1, (15384), 10.1038/s41598-021-94887-x).  Scientific Reports.  11. 2021
2021 Positron emission tomography imaging with 89Zr-labeled anti-CD8 cys-diabody reveals CD8+ cell infiltration during oncolytic virus therapy in a glioma murine model.  Scientific Reports.  11. 2021
2021 Predicting Schwannoma Growth in a Tumor Model Using Targeted Imaging 2021
2020 Consensus Conference Statement on the General Use of Near-Infrared Fluorescence Imaging and Indocyanine Green Guided Surgery: Results of a Modified Delphi Study..  Annals of Surgery.  2020
2020 A cell-penetrating MARCKS mimetic selectively triggers cytolytic death in glioblastoma.  Oncogene.  39:6961-6974. 2020
2020 Fluorescently Labeled Cetuximab-IRDye800 for Guided Surgical Excision of Ameloblastoma: A Proof of Principle Study.  Journal of Oral and Maxillofacial Surgery.  78:1736-1747. 2020
2020 Comparison of panitumumab-IRDye800CW and 5-aminolevulinic acid to provide optical contrast in a model of glioblastoma multiforme.  Molecular Cancer Therapeutics.  19:1922-1929. 2020
2020 Targeting MMP-14 for dual PET and fluorescence imaging of glioma in preclinical models 2020
2020 Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancer.  PLoS ONE.  15. 2020
2020 Surgical margins in oral cavity squamous cell carcinoma: Current practices and future directions 2020
2019 Fluorescence Imaging of Nerves during Surgery.  Annals of Surgery.  270:69-76. 2019
2019 Panitumumab-IRDye800CW for Fluorescence-Guided Surgical Resection of Colorectal Cancer.  Journal of Surgical Research.  239:44-51. 2019
2019 Proceedings: Pathways for successful translation of new imaging agents and modalities—phase III studies.  Journal of Nuclear Medicine.  60:736-744. 2019
2019 Genetic strategy to decrease complement activation with adenoviral therapies.  PLoS ONE.  14. 2019
2019 Adjuvant anti-angiogenic therapy enhances chemotherapeutic uptake in a murine model of head and neck cancer *.  Journal of Drug Targeting.  27:193-200. 2019
2019 Current and future imaging methods for evaluating response to immunotherapy in neuro-oncology.  Theranostics.  9:5085-5104. 2019
2018 Determination of tumor margins with surgical specimen mapping using near-infrared fluorescence.  Cancer Research.  78:5144-5154. 2018
2018 Ultrasound-Triggered Delivery of Anticancer Therapeutics from MRI-Visible Multilayer Microcapsules.  Advanced Therapeutics.  1. 2018
2018 Evaluation of optical imaging agents in a fluorescence-guided surgical model of head and neck cancer.  Surgical Oncology.  27:225-230. 2018
2018 Evaluation of fluorescence-guided surgery agents in a murine model of soft tissue fibrosarcoma.  Journal of Surgical Oncology.  117:1179-1187. 2018
2018 Recommendations for reporting on emerging optical imaging agents to promote clinical approval.  Theranostics.  8:5336-5347. 2018
2018 Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers..  Theranostics.  8:2488-2495. 2018
2017 Characterizing the detection threshold for optical imaging in surgical oncology.  Journal of Surgical Oncology.  116:898-906. 2017
2017 Fluorescence Imaging for Cancer Screening and Surveillance 2017
2017 T 1-Enhanced MRI-visible nanoclusters for imaging-guided drug delivery.  Nanoscale.  9:11785-11792. 2017
2017 Sensitivity and specificity of cetuximab-IRDye800CW to identify regional metastatic disease in head and neck cancer.  Clinical Cancer Research.  23:4744-4752. 2017
2017 Effects of an Unlabeled Loading Dose on Tumor-Specific Uptake of a Fluorescently Labeled Antibody for Optical Surgical Navigation 2017
2017 Laser-assisted indocyanine green dye angiography for postoperative fistulas after salvage laryngectomy.  JAMA Otolaryngology-Head and Neck Surgery.  143:775-781. 2017
2017 Beyond the margins: Real-time detection of cancer using targeted fluorophores.  Nature Reviews Clinical Oncology.  14:347-364. 2017
2017 Regulatory aspects of optical methods and exogenous targets for cancer detection.  Cancer Research.  77:2197-2206. 2017
2017 Characterizing the utility and limitations of repurposing an open-field optical imaging device for fluorescence-guided surgery in head and neck cancer patients.  Journal of Nuclear Medicine.  58:246-251. 2017
2017 Effects of Neoadjuvant Chemotherapy and Radiotherapy on Flap Perfusion in a Novel Mouse Model Using Standard Clinical Assessment and Near-Infrared Fluorescence Angiography 2017
2017 Oncologic Procedures Amenable to Fluorescence-guided Surgery.  Annals of Surgery.  266:36-47. 2017
2017 Specimen mapping in head and neck cancer using fluorescence imaging.  Laryngoscope Investigative Otolaryngology.  2:447-452. 2017
2016 Antiangiogenic antibody improves melanoma detection by fluorescently labeled therapeutic antibodies 2016
2016 Photoimmunotherapy of residual disease after incomplete surgical resection in head and neck cancer models.  Cancer Medicine.  5:1526-1534. 2016
2016 Biodistribution Study of Intravenously Injected Cetuximab-IRDye700DX in Cynomolgus Macaques 2016
2016 Fluorescence imaging to localize head and neck squamous cell carcinoma for enhanced pathological assessment.  Journal of Pathology: Clinical Research.  2:104-112. 2016
2016 On the horizon: Optical imaging for cutaneous squamous cell carcinoma 2016
2016 SPARC-independent delivery of nab-paclitaxel without depleting tumor stroma in patient-derived pancreatic Cancer xenografts.  Molecular Cancer Therapeutics.  15:680-688. 2016
2016 Standardized model for predicting flap failure using indocyanine green dye.  Progress in Biomedical Optics and Imaging - Proceedings of SPIE.  9696. 2016
2016 Successful translation of fluorescence navigation during oncologic surgery: A consensus report.  Journal of Nuclear Medicine.  57:144-150. 2016
2015 Molecular Ultrasound Imaging of Tissue Inflammation Using an Animal Model of Acute Kidney Injury 2015
2015 Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW.  British Journal of Neurosurgery.  29:850-858. 2015
2015 Safety and tumor specificity of cetuximab-IRDye800 for surgical navigation in head and neck cancer.  Clinical Cancer Research.  21:3658-3666. 2015
2015 A ratiometric threshold for determining presence of cancer during fluorescence-guided surgery.  Journal of Surgical Oncology.  112:2-8. 2015
2015 In Vivo Fluorescence Immunohistochemistry: Localization of Fluorescently Labeled Cetuximab in Squamous Cell Carcinomas.  Scientific Reports.  5. 2015
2015 IND-Directed Safety and Biodistribution Study of Intravenously Injected Cetuximab-IRDye800 in Cynomolgus Macaques 2015
2015 Breast Cancer Imaging Using the Near-Infrared Fluorescent Agent, CLR1502..  Molecular Imaging.  14:7290201400040. 2015
2015 Laparoscopic fluorescent visualization of the ureter with intravenous IRDye800CW 2015
2015 The status of contemporary image-guided modalities in oncologic surgery.  Annals of Surgery.  261:46-55. 2015
2015 Time-dependent pretreatment with bevacuzimab increases tumor specific uptake of cetuximab in preclinical oral cavity cancer studies.  Cancer Biology and Therapy.  16:790-798. 2015
2014 A standardized light-emitting diode device for photoimmunotherapy.  Journal of Nuclear Medicine.  55:1893-1898. 2014
2014 Volumetric contrast-enhanced ultrasound imaging of renal perfusion.  Journal of Ultrasound in Medicine.  33:1427-1437. 2014
2014 A dual-reporter, diagnostic vector for prostate cancer detection and tumor imaging 2014
2014 Antibody-based imaging strategies for cancer.  Cancer and Metastasis Reviews.  33:809-822. 2014
2014 Biodistribution of P-selectin targeted microbubbles.  Journal of Drug Targeting.  22:387-394. 2014
2014 Breast cancer imaging using the near-infrared fluorescent agent, CLR1502.  Molecular Imaging.  13. 2014
2014 Ultrasound-stimulated drug delivery for treatment of residual disease after incomplete resection of head and neck cancer.  Ultrasound in Medicine and Biology.  40:755-764. 2014
2013 Alpha-CaMKII plays a critical role in determining the aggressive behavior of human osteosarcoma 2013
2013 Optical fluorescent imaging to monitor temporal effects of microbubble-mediated ultrasound therapy.  IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.  60:281-289. 2013
2013 An Animal Model Allowing Controlled Receptor Expression for Molecular Ultrasound Imaging.  Ultrasound in Medicine and Biology.  39:172-180. 2013
2013 Enhancement of Adenovirus Delivery after Ultrasound-Stimulated Therapy in a Cancer Model.  Ultrasound in Medicine and Biology.  39:2374-2381. 2013
2012 Systemic delivery of a breast cancer-detecting adenovirus using targeted microbubbles.  Cancer Gene Therapy.  19:545-552. 2012
2012 Molecular targeting of ultrasonographic contrast agent for detection of head and neck squamous cell carcinoma 2012
2012 Microbubble-mediated ultrasonic techniques for improved chemotherapeutic delivery in cancer.  Journal of Drug Targeting.  20:43-54. 2012
2011 Fibroblast growth factor receptor mediates fibroblast-dependent growth in EMMPRIN-depleted head and neck cancer tumor cells 2011
2011 Model System Using Controlled Receptor Expression for Evaluating Targeted Ultrasound Contrast Agents.  Ultrasound in Medicine and Biology.  37:1306-1313. 2011
2011 A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature.  Journal of Ultrasound in Medicine.  30:921-931. 2011
2011 A genetic strategy for combined screening and localized imaging of breast cancer 2011
2010 Determination of breast cancer response to bevacizumab therapy using contrast-enhanced ultrasound and artificial neural networks.  Journal of Ultrasound in Medicine.  29:577-585. 2010
2009 Death receptor 5 agonist TRA8 in combination with the bisphosphonate zoledronic acid attenuated the growth of breast cancer metastasis.  Cancer Biology and Therapy.  8:1109-1116. 2009
2008 Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenograftsby diffusion-weighted magnetic resonance imaging.  Cancer Research.  68:8369-8376. 2008
2008 Breast tumor xenografts: Diffusion-weighted MR imaging to assess early therapy with novel apoptosis-inducing anti-DR5 antibody.  Radiology.  248:844-851. 2008
2008 Endotoxin-induced proteolytic reduction in hepatic growth hormone (GH) receptor: A novel mechanism for GH insensitivity 2008

Chapter

Year Title Altmetric
2015 Translation of therapeutic antibodies for intraoperative fluorescence imaging.  25-33. 2015

Principal Investigator On

Investigator On

  • A Specific Screening Strategy to Reduce Prostate Cancer Mortality  awarded by DOD - ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY
  • Comprehensive Cancer Center Core Support Grant  awarded by National Cancer Institute/NIH/DHHS
  • Comprehensive Cancer Center Core Support Grant  awarded by National Cancer Institute/NIH/DHHS
  • Comprehensive Cancer Center Core Support Grant  awarded by National Cancer Institute/NIH/DHHS
  • Comprehensive Cancer Center Core Support Grant - Preclinical Imaging Shared Facility  awarded by National Cancer Institute/NIH/DHHS
  • Comprehensive Cancer Center Core Support Grant - Preclinical Imaging Shared Facility  awarded by National Cancer Institute/NIH/DHHS
  • Imaging Guided Surgery using Fluorescently Labeled Cetuximab  awarded by National Cancer Institute/NIH/DHHS
  • Lumina III System for UAB Optical Imaging  awarded by NIH - OFFICE OF THE DIRECTOR
  • Non-Invasive Imaging of Ameloblastomas  awarded by National Institute of Dental and Craniofacial Research/NIH/DHHS
  • Phase 1, Open-Label Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Cetuximab-IRDye800 as an Optical Imaging Agent to Detect Cancer during Surgical Procedures  awarded by Stanford University
  • Phase I, Open-label Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Head and Neck Cancer During Surgical Procedures  awarded by Stanford University
  • Private Grant  awarded by LICOR, INC.
  • Research Training Program in Surgical Oncology  awarded by National Cancer Institute/NIH/DHHS
  • UAB-UCSD O'Brien Center for Acute Kidney Injury Research  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
  • UAB-UCSD O'Brien Center for Acute Kidney Injury Research - Core B  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS

    • Education And Training

  • Doctor of Philosophy in Physiology, Pathology and Related Sciences, University of Alabama at Birmingham 2011
  • Bachelor of Science or Mathematics, University of Alabama at Birmingham 2002

    • Full Name

  • Jason Warram